Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Yael Vilner"'
Autor:
Amir Krivoy, Roy Onn, Yael Vilner, Eldar Hochman, Shira Weizman, Amir Paz, Shmuel Hess, Roi Sagy, Shiri Kimhi-Nesher, Ehud Kalter, Tal Friedman, Zvi Friedman, Gil Bormant, Sharon Trommer, Avi Valevski, Abraham Weizman
Publikováno v:
EBioMedicine, Vol 26, Iss C, Pp 138-145 (2017)
Background: While accumulating evidence suggests that vitamin D deficiency may be involved in the risk to develop schizophrenia and its outcome, there are no studies on vitamin D supplementation in this context. We sought to assess the effect of vita
Externí odkaz:
https://doaj.org/article/944143d687cd49e69af5499f4226db81
Autor:
Abraham Weizman, Michal Taler, Amir Krivoy, Sarah Hollander, Yael Vilner, Mirjana Selaković, Kyra-Verena Sendt, Eldar Hochman
Publikováno v:
Schizophrenia Research. 192:226-231
Clozapine is the only available therapy for about 30% of schizophrenia patients otherwise refractory to antipsychotics. Unfortunately, the mechanism of action of the drug is still unknown and there are no biomarkers that can predict a positive respon
Autor:
Zvi Friedman, Shira Weizman, Sharon Trommer, Yael Vilner, Eldar Hochman, Ehud Kalter, Avi Valevski, Abraham Weizman, Roy Onn, Amir Krivoy, Tal Friedman, Shmuel Hess, Shiri Kimhi-Nesher, Gil Bormant, Roi Sagy, Amir Paz
Publikováno v:
EBioMedicine
EBioMedicine, Vol 26, Iss C, Pp 138-145 (2017)
Krivoy, A, Onn, R, Vilner, Y, Hochman, E, Weizman, S, Paz, A, Hess, S, Sagy, R, Kimhi-Nesher, S, Kalter, E, Friedman, T, Friedman, Z, Bormant, G, Trommer, S, Valevski, A & Weizman, A 2017, ' Vitamin D Supplementation in Chronic Schizophrenia Patients Treated with Clozapine : A Randomized, Double-Blind, Placebo-controlled Clinical Trial ', EBioMedicine . https://doi.org/10.1016/j.ebiom.2017.11.027
EBioMedicine, Vol 26, Iss C, Pp 138-145 (2017)
Krivoy, A, Onn, R, Vilner, Y, Hochman, E, Weizman, S, Paz, A, Hess, S, Sagy, R, Kimhi-Nesher, S, Kalter, E, Friedman, T, Friedman, Z, Bormant, G, Trommer, S, Valevski, A & Weizman, A 2017, ' Vitamin D Supplementation in Chronic Schizophrenia Patients Treated with Clozapine : A Randomized, Double-Blind, Placebo-controlled Clinical Trial ', EBioMedicine . https://doi.org/10.1016/j.ebiom.2017.11.027
Background While accumulating evidence suggests that vitamin D deficiency may be involved in the risk to develop schizophrenia and its outcome, there are no studies on vitamin D supplementation in this context. We sought to assess the effect of vitam
Publikováno v:
Schizophrenia Bulletin
Background Vitamin D deficiency is highly prevalent in patients with psychosis. While accumulating data suggests that vitamin D deficiency may be involved in the clinical and metabolic outcomes of schizophrenia, there are no vitamin D supplementation